Group 1 - The next earnings date for Nike is projected to be June 26, with earnings estimates of $0.11 per share on revenue of $10.70 billion [1] - Nike has demonstrated impressive long-term earnings per share growth [4] - The company has also shown significant revenue growth, which can lead to stock volatility around earnings reports, attracting options traders [5] Group 2 - Nike's current dividend yield stands at 2.67%, indicating a stable return for dividend investors [6]

Waste Management, Inc. (NYSE: WM ) has good revenue growth potential in the near as well as long term. The weather-related disruptions that impacted revenue growth in Q1 2025 should no longerI have over 15 years of experience investing and have provided research services to mid-sized hedge funds with assets under management between $100 and $500 million. I also have had a brief stint as a sell-side analyst. I am now focusing primarily on managing my own money and my purpose here is to share my views and ben ...

Jeremy Allaire, CEO of Circle Internet Group, the issuer of one of the world's biggest stablecoins, and Circle co-founder Sean Neville pose outside the New York Stock Exchange (NYSE), on the day of the company's IPO in New York City, U.S., June 5, 2025.Shares of Circle and Coinbase rallied on Wednesday, as Wall Street cheered the Senate's passage of the GENIUS Act, which would establish a federal framework for U.S. dollar-pegged stablecoins. Circle, the issuer of the USDC stablecoin, rose 22% following the ...

Core Insights - Pomerantz LLP is investigating claims on behalf of investors of Sarepta Therapeutics, focusing on potential securities fraud or unlawful business practices by the company and its officers [1][5] Company Developments - On March 18, 2025, Sarepta disclosed the death of a patient with Duchenne muscular dystrophy following treatment with its drug ELEVIDYS, resulting in a stock price drop of $27.81 per share, or 27.44%, closing at $73.54 [3] - On June 16, 2025, Sarepta reported a second fatality from acute liver failure in a patient treated with ELEVIDYS, leading to the halting of its ongoing clinical trial and a temporary suspension of the drug's distribution for non-ambulatory patients. This news caused Sarepta's stock price to fall by $15.24 per share, or 42.12%, closing at $20.94 [4]

Key Takeaways AGCO is benefiting from strong demand for Precision Agriculture and Fendt equipment and parts. A joint venture with Trimble and a $700M business sale support AGCO's transformation goals. Rising U.S. farm income in 2025 is expected to lift margins, offsetting crop price and sales volume pressures.AGCO Corporation (AGCO) benefits from strong demand for its Precision Agriculture Business, technology-rich Fendt full lineup of equipment and replacement parts. The company's focus on innovation and ...

Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Grocery Outlet Holding Corp. (GO) or Kimberly-Clark (KMB) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style S ...

Investors looking for stocks in the Internet - Software sector might want to consider either StoneCo Ltd. (STNE) or F5 Networks (FFIV) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank is a proven strategy that targets companies with p ...

Investors with an interest in Building Products - Heavy Construction stocks have likely encountered both Great Lakes Dredge & Dock (GLDD) and Dycom Industries (DY) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets companies with positive earnings ...

Core Viewpoint - Grupo Financiero Banorte SAB de CV (GBOOY) is currently viewed as a better value opportunity compared to Brookfield Asset Management (BAM) based on various financial metrics and rankings [1]. Group 1: Company Rankings - GBOOY has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while BAM has a Zacks Rank of 3 (Hold) [3]. - The Zacks Rank system emphasizes companies with positive estimate revision trends, which supports GBOOY's improving earnings outlook [3]. Group 2: Valuation Metrics - GBOOY has a forward P/E ratio of 8.11, significantly lower than BAM's forward P/E of 32.65, suggesting GBOOY is undervalued [5]. - The PEG ratio for GBOOY is 0.95, while BAM's PEG ratio is 1.96, indicating GBOOY's expected earnings growth is more favorable relative to its price [5]. - GBOOY's P/B ratio is 1.84, compared to BAM's P/B of 9.86, further highlighting GBOOY's superior valuation [6]. Group 3: Value Grades - GBOOY holds a Value grade of A, while BAM has a Value grade of F, indicating a significant difference in perceived value between the two stocks [6]. - The combination of solid earnings outlook and favorable valuation metrics positions GBOOY as the superior value option at this time [6].

Investors interested in stocks from the Electronics - Miscellaneous Products sector have probably already heard of Flex (FLEX) and Garmin (GRMN) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The proven Zacks Rank emphasizes companies with positive estimate revision trends ...